Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Pandemic H5N1 Influenza Vaccine in Adults
NCT00319098Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Jan 2007
- Modality
- Split/Subunit Vaccines, Whole Inactivated Vaccines
- Countries
- 7
01
Overview
A Phase 3 trial of Influenza A (H5N1) vaccine in Influenza A H5N1 infection (H5N1), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
Influenza A (H5N1) vaccine
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00319098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319098.